MetaCap

Vaxcyte Statistics

NASDAQ: PCVXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

55.39-2.97 (-5.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Vaxcyte by the numbers

Vaxcyte has a market capitalization of $8.77 billion based on 158.30M shares outstanding. With trailing EPS of $-8.05, Vaxcyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 4.2% below its 200-day average.

Average daily trading volume is 2.19M shares, or about $121.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PCVX valuation vs. peer median

PCVX compared with the median of 8 peer companies
MetricPCVXPeer medianDifference
Market cap$8.77B$9.50B-8%
Avg. volume2.19M1.33M+65%

Peer median across 8 companies: KRYS, KYMR, QGEN, HALO, CGON, RGEN, TWST, IMVT.

Valuation

Price and trading

Previous close
58.36
Open
57.77
Day range
55.27 – 58.48
52-week range
42.40 – 90.75
52-week change
+15.93%
Beta
—
Volume
1.91M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
8.77B
Forward Pe
-8.06
Eps
-8.05
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
90.75
Week52 Low
42.40
Avg Volume
2.19M
Shares Outstanding
158.30M
Ma50
62.11
Ma200
57.79
Earnings Date
Nov 4, 2026
Pct From52w High
-38.96%
Pct From52w Low
30.64%

Related